DocMorris (ZRSEF) Stock Price, News & Analysis

Company Overview

DocMorris is a leading online pharmacy in Europe offering prescription medications, over-the-counter products and health care supplies through its digital platform. The company operates a fully licensed mail-order pharmacy service, enabling patients to manage their prescriptions online, schedule automated refills and access customer support from certified pharmacists.

Established in the late 1980s in the Netherlands, DocMorris was acquired by Switzerland-based Zur Rose Group AG in 2012. Since then, it has expanded its e-pharmacy operations to serve customers across Germany, the Netherlands, Austria and other European markets. The brand leverages integrated logistics and distribution networks to fulfil orders directly to consumers’ homes, combining traditional pharmacy expertise with digital health technology.

Beyond dispensing medications, DocMorris invests in telemedicine services and digital health solutions, including electronic prescribing systems and medication adherence tools. As part of the Zur Rose Group, the company benefits from shared innovation initiatives in e-health and last-mile delivery. The brand’s strategy and growth are guided by Zurich-based leadership under CEO Christof Vetter, focusing on enhancing patient access to pharmaceutical care across Europe.

Key Stats

• Today's Range: $10.91 to $10.91
• 50-Day Range: $10.91 to $16.22
• 52-Week Range: $10.91 to $108.05
• Volume: N/A
• Average Volume: 125 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZRSEF Stock Analysis - Frequently Asked Questions

How have ZRSEF shares performed this year?

DocMorris' stock was trading at $23.8640 at the beginning of the year. Since then, ZRSEF stock has decreased by 54.3% and is now trading at $10.91.

How do I buy shares of DocMorris?

Shares of ZRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/19/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ZRSEF
• CIK: N/A
• Web: www.zurrosegroup.com
• Phone: (152) 724-0020
• Fax: N/A
• Employees: 1,453
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A